Novo Nordisk Diabetes Education Materials

Novo Nordisk Expands AI Partnership With Valo Health

Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes

Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and billions on the back end—to apply artificial intelligence to up to 20 programs.

U.S. News & World Report · 2d

Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

Business Insider · 2d

Novo Nordisk, Valo Health expand drug discovery collaboration

Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, ty

pharmaphorum2d

Novo Nordisk: survival of the fittest applies in diabetes and obesity market

Diabetes specialist Novo Nordisk is feeling the heat from increasingly price conscious US payers. It needs next generation innovation and growth in emerging markets to keep ahead of competitors ...

Yahoo Finance4d

Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug

rendering these products less effective or ineffective for conditions such as type 2 diabetes, cardiovascular disease, and chronic weight management. Novo Nordisk also noted 44 documented ...

GEN2d

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Novo Nordisk Expands AI Partnership With Valo Health

Trending now